The clinical and epidemiologic profile of community-associated methicillin-resistant Staphylococcus aureus infection among pediatric patients admitted at the Philippine General Hospital
- Author:
Mercy Jeane Uy Aragon
1
;
Ma. Liza Gonzales
1
;
Anna Ong-Lim
1
Author Information
- Publication Type:Journal Article
- MeSH: Human; Male; Female; Adolescent; Child; Child Preschool; Infant; Infant Newborn; STAPHYLOCOCCUS AUREUS; TETRACYCLINE; CLINDAMYCIN; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; GENTAMICINS; VANCOMYCIN
- From: Pediatric Infectious Disease Society of the Philippines Journal 2011;12(1):2-10
- CountryPhilippines
- Language:English
- Abstract: Background: Several studies have reported increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection among patients with no predisposing factors. This paper aims to determine the clinical and epidemiologic profile of community-associated MRSA (CA-MRSA) infection among children admitted at UP-PGH. Methodology: A retrospective review of the medical records of patients 0-to-18 years old with S. aureus isolate admitted at University of the Philippines-Philippine General Hospital (UP PGH) from January 1, 2007 to December 31, 2008 was conducted. S. aureus isolates were classified as methicillin-susceptible S. aureus (MSSA), CA-MRSA or healthcare-associated MRSA (HA-MRSA). Risk factors for MRSA acquisition were identified. Demographic data, site of infection, outcome, and antibiotic susceptibility patterns were compared. Results: S. aureus was isolated in 382 children. Medical records of 219 (57.33%) patients were available for review. Of the 219 patients, 40.64% had MSSA, 15.07% had CA-MRSA, and 44.3% had HA-MRSA isolates. The prevalence of CA-MRSA is seven per 1000 admissions. There was no statistical difference between the age, sex, outcome and the site of infection among the three groups. The most common source of isolates was exudates, followed by blood. There were statistically significant differences in the resistance patterns of S. aureus isolates, with MSSA and CA-MRSA having lower resistance rates (<10%) as compared to HAMRSA (>40%) and non-beta lactam antibiotics such as tetracycline, clindamycin, cotrimoxazole, gentamicin and vancomycin. Conclusion: This study showed that MRSA infection is no longer limited to patients with predisposing factors. The type of S. aureus infection cannot be predicted based on clinical and demographic profile of patients. Based on the susceptibility patterns in this study, CA-MRSA may be treated with tetracycline, clindamycin, cotrimoxazole, gentamicin and vancomycin.
- Full text:2024080713394779874jo38_ja01.pdf
